Takeda Pharmaceutical Company Limited - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
TAK New York 2834 www.takeda.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Takeda Pharmaceutical Company Limited

Ascentage Pharma Group International H1 Earnings Call Highlights - Aug 20th, 2026 9:04 am
Asian Equities Traded in the US as American Depositary Receipts Track Lower in Tuesday Trading - Aug 18th, 2026 8:41 am
Wall Street Analysts Think Takeda Pharmaceutical Co. (TAK) Could Surge 26.41%: Read This Before Placing a Bet - Aug 18th, 2026 7:55 am
WuXi Biologics Recognized for Industry Top Sustainable Biopharma Practices Empowering the Industry's Transformation Through Green CRDMO - Aug 18th, 2026 1:04 am
Should Value Investors Buy Takeda Pharmaceutical Co. (TAK) Stock? - Aug 17th, 2026 7:40 am
Best Income Stocks to Buy for August 17th - Aug 17th, 2026 6:29 am
New Strong Buy Stocks for August 17th - Aug 17th, 2026 3:51 am
Vinod Khosla Says AI Is Creating a ‘Hyperabundance’ of New Drugs, but Testing Is Still ‘18th-Century’ - Aug 14th, 2026 9:30 pm
Can Keros Therapeutics (KROS)’s $20M Takeda Pharmaceutical Company Limited (TAK) Milestone Unlock a Billion-Dollar Opportunity? - Aug 14th, 2026 5:37 pm
Can Asceniv Help ADMA Stock Combat IG Market Challenges? - Aug 13th, 2026 11:47 am
Silence cashes in on ‘differentiated’ data; UK reaffirms support for childhood vaccines - Aug 12th, 2026 3:11 am
Takeda Pharmaceutical (TSE:4502) Wins ORZEYFUL Approval, Where Does Fair Value Sit? - Aug 11th, 2026 5:18 pm
A Profitable Rare-Disease Prize: Who Might Snap Up BioCryst? - Aug 11th, 2026 7:20 am
Takeda (TAK) Q1 2026 Earnings Call Transcript - Aug 7th, 2026 7:32 pm
DNLI Q2 Loss Narrows, Avlayah Sales Drive Strong Launch Momentum - Aug 7th, 2026 12:31 pm
Takeda nets first-in-class advantage on narcolepsy drug’s FDA go-ahead - Aug 6th, 2026 8:11 am
Takeda approval ushers in new wave of sleep drugs - Aug 6th, 2026 6:08 am